| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.9M | -9.9% | -26.5% |
| Cost of Revenue | $7.3M | +1.2% | -8.9% |
| Gross Profit | $2.5M | -31.6% | -52.9% |
| R&D Expense | $3.0M | +4.3% | +30.6% |
| SG&A Expense | $4.4M | -6.0% | -4.4% |
| Operating Income | -$4.6M | -14.3% | -207.2% |
| Pre-tax Income | -$4.4M | -56.7% | -256.9% |
| Income Tax | -$1.2M | -61.4% | -459.4% |
| Net Income | -$3.2M | -55.0% | -214.2% |
| EPS (Basic) | -$0.11 | -57.1% | -266.7% |
| EPS (Diluted) | -$0.11 | -57.1% | -266.7% |
| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.8M | +35.8% | -4.3% |
| Inventory | $42.7M | +2.1% | -2.4% |
| Current Assets | $88.2M | +4.9% | -0.4% |
| Total Assets | $148.7M | +3.2% | +4.5% |
| Current Liabilities | $8.3M | -30.3% | -29.1% |
| Total Liabilities | $18.0M | -17.2% |
| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | -415.2% | — |
| Capital Expenditures | $1.9M | +33.6% | — |
| Investing Cash Flow | -$3.7M | -163.0% | — |
| Financing Cash Flow | $9.6M | +6188.0% | — |
| Free Cash Flow | -$3.3M | -97.9% | — |
| -6.0% |
| Stockholders' Equity | $130.8M | +6.8% | +6.2% |